Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor

Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook

(2020) Josep Garcia et al.   CANCER TREATMENT REVIEWS

Novel strategy of ovarian cancer implantation: Pre‐invasive growth of fibrin‐anchored cells with neovascularization

(2019) Ayumi Matsuoka et al.   CANCER SCIENCE

The multi-factorial nature of clinical multidrug resistance in cancer

(2019) Yehuda G. Assaraf et al.   DRUG RESISTANCE UPDATES

Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling

(2018) Wei-Hui Hu et al.   FASEB JOURNAL

A Moving Mesh Method for Mathematical Model of Capillary Formation in Tumor Angiogenesis

(2018) Mina Bagherpoorfard et al.   Iranian Journal of Science and Technology Transaction A-Science

Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors

(2018) THOMAS COLLOT et al.   ANTICANCER RESEARCH

Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling

(2018) Wei-Hui Hu et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

The Therapeutic Potential of Piceatannol, a Natural Stilbene, in Metabolic Diseases: A Review

(2017) Jonathan Kershaw et al.   JOURNAL OF MEDICINAL FOOD

A Comprehensive Review on the Chemotherapeutic Potential of Piceatannol for Cancer Treatment, with Mechanistic Insights

(2016) Mohamed Ali Seyed et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Antiangiogenic therapy in oncology: current status and future directions

(2016) Gordon C Jayson et al.   LANCET

Mechanisms and regulation of endothelial VEGF receptor signalling

(2016) Michael Simons et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration

(2015) Hyerim Song et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Absorption and Metabolism of Piceatannol in Rats

(2014) Yuko Setoguchi et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Effects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum

(2014) Casper Hempel et al.   MALARIA JOURNAL

Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases

(2014) Yeong Kim et al.   ONCOLOGY REPORTS

A Review of the Pharmacological Effects of Piceatannol on Cardiovascular Diseases

(2014) Yee-Ling Tang et al.   PHYTOTHERAPY RESEARCH

Pharmacokinetics, pharmacodynamics and pre-clinical characteristics of ophthalmic drugs that bind VEGF

(2014) Michael W Stewart   Expert Review of Clinical Pharmacology

Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab

(2013) Hyung Cho et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials

(2013) H. Fang et al.   CANCER RESEARCH

Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis

(2012) L. Ouyang et al.   CELL PROLIFERATION

Bioavailability of resveratrol

(2011) Thomas Walle   Annals of the New York Academy of Sciences

Developmental and Pathological Angiogenesis

(2011) Alicia S. Chung et al.   Annual Review of Cell and Developmental Biology

Tumor Metastasis: Molecular Insights and Evolving Paradigms

(2011) Scott Valastyan et al.   CELL

Fast docking using the CHARMM force field with EADock DSS

(2011) Aurélien Grosdidier et al.   JOURNAL OF COMPUTATIONAL CHEMISTRY

Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling

(2011) Gyoo Taik Kwon et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Biological activity of piceatannol: Leaving the shadow of resveratrol

(2011) Hanna Piotrowska et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

(2011) Ana-Maria Florea et al.   Cancers

Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity

(2009) Yeo Myeong Lee et al.   CANCER LETTERS